Scott M. Lassman is the Principal at Lassman Law+Policy, a boutique law firm located in Washington, D.C. that focuses on solving its clients’ most complicated FDA-related problems. Scott provides strategic advice and advocacy to small, mid-size and large pharmaceutical, biotechnology and medical device companies, as well as the trade associations that represent them and the investors who fund them. His practice covers all aspects of FDA regulatory law, with a special focus on exclusivity, biosimilars, product approval and policy matters. Before starting Lassman Law+Policy, Scott was the Chair of the FDA Practice Group at a leading, international law firm, a partner at a well-regarded FDA boutique, and the head FDA regulatory attorney at a major pharmaceutical trade association. Scott graduated from Yale University (B.A.), the University of Texas at Austin (M.A.), and the University of Virginia School of Law (J.D.).
Wednesday, September 16, 2020
10:35 AM – 11:30 AM EDT